Engineering the alternative oxidase gene to better understand and counteract mitochondrial defects: state of the art and perspectives
- 28 March 2014
- journal article
- review article
- Published by Wiley in British Journal of Pharmacology
- Vol. 171 (8) , 2243-2249
Abstract
Mitochondrial disorders are nowadays recognized as impinging on most areas of medicine. They include specific and widespread organ involvement, including both tissue degeneration and tumour formation. Despite the spectacular progresses made in the identification of their underlying molecular basis, effective therapy remains a distant goal. Our still rudimentary understanding of the pathophysiological mechanisms by which these diseases arise constitutes an obstacle to developing any rational treatments. In this context, the idea of using a heterologous gene, encoding a supplemental oxidase otherwise absent from mammals, potentially bypassing the defective portion of the respiratory chain, was proposed more than 10 years ago. The recent progress made in the expression of the alternative oxidase in a wide range of biological systems and disease conditions reveals great potential benefit, considering the broad impact of mitochondrial diseases. This review addresses the state of the art and the perspectives that can be now envisaged by using this strategy.Linked Articles: This article is part of a themed issue on Mitochondrial Pharmacology: Energy, Injury & Beyond. To view the other articles in this issue visit http://dx.doi.org/10.1111/bph.2014.171.issue‐8Keywords
This publication has 47 references indexed in Scilit:
- Mitochondrial geneticsBritish Medical Bulletin, 2013
- Alternative Oxidase Expression in the Mouse Enables Bypassing Cytochrome c Oxidase Blockade and Limits Mitochondrial ROS OverproductionPLOS Genetics, 2013
- Alternative oxidase modulates leaf mitochondrial concentrations of superoxide and nitric oxideNew Phytologist, 2012
- Stabilization of Hypoxia-inducible Factor-1α Protein in Hypoxia Occurs Independently of Mitochondrial Reactive Oxygen Species ProductionJournal of Biological Chemistry, 2010
- Expression of the yeast NADH dehydrogenase Ndi1 in Drosophila confers increased lifespan independently of dietary restrictionProceedings of the National Academy of Sciences, 2010
- Expression of the alternative oxidase complements cytochrome c oxidase deficiency in human cellsEMBO Molecular Medicine, 2009
- Cytochrome c oxidase deficiency in neurons decreases both oxidative stress and amyloid formation in a mouse model of Alzheimer's diseaseProceedings of the National Academy of Sciences, 2007
- Mutations in Cytochrome c Oxidase Subunit VIa Cause Neurodegeneration and Motor Dysfunction in DrosophilaGenetics, 2007
- A Mitochondrial Paradigm of Metabolic and Degenerative Diseases, Aging, and Cancer: A Dawn for Evolutionary MedicineAnnual Review of Genetics, 2005
- Aging: A Theory Based on Free Radical and Radiation ChemistryJournal of Gerontology, 1956